XPost: soc.support.fat-acceptance, alt.politics.republicans, sac.politics   
   XPost: talk.politics.guns   
   From: noreply@mixmin.net   
      
   Time for Ozempic to walk the plank?   
      
   Top dietitians in Australia this week are waving a red flag about an   
   unforeseen impact of the GLP-1 class of weight-loss drugs, including   
   Ozempic, Wegovy and Mounjaro.   
      
   In a new systematic review of existing research, led by professor Clare   
   Collins of the Newcastle School of Health Sciences in New South Wales,   
   Australia, it appears that very few global trials of the drugs have   
   taken into consideration what and how much patients are eating while   
   using them.   
      
   This, experts have said, means many patients have been functionally   
   malnourished — sometimes developing serious vitamin deficiencies like   
   scurvy.   
      
   Part of what makes these drugs so effective for weight loss and diabetes   
   management is their ability to suppress appetite. But not eating, or not   
   eating enough of the right stuff, is simply not a sustainable path   
   forward for anyone, regardless of whether or not they’re using a GLP-1.   
   And dietitians are calling for more oversight.   
      
   “A reduction in body weight does not automatically mean the person is   
   well-nourished or healthy,” Collins told the Australian Financial   
   Review. “Nutrition plays a critical role in health and right now it’s   
   largely missing from the evidence.”   
      
   One high-profile case of scurvy arose last year, when British pop singer   
   Robbie Williams was diagnosed with what he called a “17th century pirate   
   disease.” He had been open about his use of injectable weight loss   
   medication for years, and has also spoken anecdotally about its   
   potential connection to his degrading eyesight.   
      
   While scurvy — a vitamin C deficiency that can be deadly if untreated —   
   posed a regular threat to sea-farers of yore, these days, it’s quite   
   rare, especially in the US, UK and Australia, where nutrient-dense diets   
   are common.   
      
   But now, Collins told the AFP that she’s heard of several doctors   
   reporting cases of scurvy. “Let’s not wait for every GP to see a case of   
   scurvy, let’s get on the front foot and link these GP chronic management   
   plans to a dietitian referral,” she said.   
      
   https://nypost.com/2026/02/09/health/people-are-getting-an-old-timey-sail   
   ors-disease-on-glp-1s/   
      
   --- SoupGate-Win32 v1.05   
    * Origin: you cannot sedate... all the things you hate (1:229/2)